CVS stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Havanec Laurie P.2023/03/01EVP and Chief People Officer93505-52332023-03-010000064803000006480388272
-
Havanec Laurie P.2023/02/28EVP and Chief People Officer93505-52332023-02-280000064803000006480388272
-
Havanec Laurie P.2023/02/27EVP and Chief People Officer93505-52332023-02-270000064803000006480388272
-
Hourican Kevin2023/02/26EVP & President, CVS Pharmacy220326-141622023-02-2600000648030000064803206164
-
Hourican Kevin2023/02/25EVP & President, CVS Pharmacy220326-141622023-02-2500000648030000064803206164
-
Havanec Laurie P.2023/02/24EVP and Chief People Officer93505-52332023-02-240000064803000006480388272
-
Chaguturu Sreekanth K2023/02/23EVP and Chief Medical Officer129192023-02-230000064803000006480312919
-
Havanec Laurie P.2023/02/22EVP and Chief People Officer93505-52332023-02-220000064803000006480388272
-
Hourican Kevin2023/02/21EVP & President, CVS Pharmacy220326-141622023-02-2100000648030000064803206164
-
Havanec Laurie P.2023/02/20EVP and Chief People Officer93505-52332023-02-200000064803000006480388272
Related News
Nebius at $191 With a $40B Backlog and a 7x Capex-to-Revenue Ratio
Itai Smidt
11.08.26
Coreaweave at $89 With a $99.4B Backlog and $30B Raised in Seven Months
Itai Smidt
11.08.26